- Home
- VCIG vs PRPO Comparison
VCIG vs PRPO Comparison
Compare VCIG & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- PRPO
- Stock Information
- Founded
- VCIG 2013
- PRPO N/A
- Country
- VCIG Malaysia
- PRPO United States
- Employees
- VCIG 58
- PRPO N/A
- Industry
- VCIG Diversified Commercial Services
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- VCIG Consumer Discretionary
- PRPO Industrials
- Exchange
- VCIG Nasdaq
- PRPO Nasdaq
- Market Cap
- VCIG 21.7M
- PRPO 22.0M
- IPO Year
- VCIG 2023
- PRPO N/A
- Fundamental
- Price
- VCIG $0.81
- PRPO $14.70
- Analyst Decision
- VCIG
- PRPO
- Analyst Count
- VCIG 0
- PRPO 0
- Target Price
- VCIG N/A
- PRPO N/A
- AVG Volume (30 Days)
- VCIG 3.8M
- PRPO 8.3K
- Earning Date
- VCIG 08-26-2025
- PRPO 08-13-2025
- Dividend Yield
- VCIG N/A
- PRPO N/A
- EPS Growth
- VCIG N/A
- PRPO N/A
- EPS
- VCIG 54.73
- PRPO N/A
- Revenue
- VCIG $27,819,290.00
- PRPO $21,242,000.00
- Revenue This Year
- VCIG N/A
- PRPO N/A
- Revenue Next Year
- VCIG N/A
- PRPO N/A
- P/E Ratio
- VCIG $0.01
- PRPO N/A
- Revenue Growth
- VCIG 36.99
- PRPO 27.05
- 52 Week Low
- VCIG $0.75
- PRPO $3.90
- 52 Week High
- VCIG $264.60
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- VCIG 32.75
- PRPO 59.12
- Support Level
- VCIG $0.75
- PRPO $13.92
- Resistance Level
- VCIG $0.93
- PRPO $15.41
- Average True Range (ATR)
- VCIG 0.10
- PRPO 0.39
- MACD
- VCIG 0.05
- PRPO -0.09
- Stochastic Oscillator
- VCIG 11.08
- PRPO 55.90
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.